Growth Metrics

Genoil (GNOLF) EPS (Basic) (2019 - 2025)

Genoil has reported EPS (Basic) over the past 7 years, most recently at -$0.0 for Q3 2025.

  • Quarterly EPS (Basic) fell 3.65% to -$0.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$0.0 through Sep 2025, up 11.58% year-over-year, with the annual reading at -$0.0 for FY2024, 70.6% up from the prior year.
  • EPS (Basic) was -$0.0 for Q3 2025 at Genoil, up from -$0.0 in the prior quarter.
  • Over five years, EPS (Basic) peaked at $0.0 in Q2 2023 and troughed at -$0.0 in Q1 2022.
  • The 5-year median for EPS (Basic) is -$0.0 (2022), against an average of -$0.0.
  • Year-over-year, EPS (Basic) crashed 472.36% in 2022 and then skyrocketed 204.13% in 2023.
  • A 5-year view of EPS (Basic) shows it stood at -$0.0 in 2021, then tumbled by 73.73% to -$0.0 in 2022, then soared by 54.43% to -$0.0 in 2023, then grew by 16.51% to -$0.0 in 2024, then skyrocketed by 90.63% to -$0.0 in 2025.
  • Per Business Quant, the three most recent readings for GNOLF's EPS (Basic) are -$0.0 (Q3 2025), -$0.0 (Q2 2025), and -$0.0 (Q1 2025).